DE60320425D1 - Ostertagia-impfstoff - Google Patents

Ostertagia-impfstoff

Info

Publication number
DE60320425D1
DE60320425D1 DE60320425T DE60320425T DE60320425D1 DE 60320425 D1 DE60320425 D1 DE 60320425D1 DE 60320425 T DE60320425 T DE 60320425T DE 60320425 T DE60320425 T DE 60320425T DE 60320425 D1 DE60320425 D1 DE 60320425D1
Authority
DE
Germany
Prior art keywords
ostertagia
vaccine
ostertagia vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60320425T
Other languages
English (en)
Other versions
DE60320425T2 (de
Inventor
Peter Geldhof
Isabel Vercauteren
Edwin Claerebout
Jozef Vercruysse
Maere Veerle De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Gent
Original Assignee
Universiteit Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Gent filed Critical Universiteit Gent
Application granted granted Critical
Publication of DE60320425D1 publication Critical patent/DE60320425D1/de
Publication of DE60320425T2 publication Critical patent/DE60320425T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60320425T 2002-09-13 2003-09-11 Ostertagia-impfstoff Expired - Lifetime DE60320425T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US243319 2002-09-13
US10/243,319 US20040052817A1 (en) 2002-09-13 2002-09-13 Ostertagia vaccine
PCT/EP2003/010189 WO2004024769A2 (en) 2002-09-13 2003-09-11 Ostertagia vaccine

Publications (2)

Publication Number Publication Date
DE60320425D1 true DE60320425D1 (de) 2008-05-29
DE60320425T2 DE60320425T2 (de) 2008-07-31

Family

ID=31991608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60320425T Expired - Lifetime DE60320425T2 (de) 2002-09-13 2003-09-11 Ostertagia-impfstoff

Country Status (11)

Country Link
US (4) US20040052817A1 (de)
EP (1) EP1539820B1 (de)
AR (1) AR041243A1 (de)
AT (1) ATE392435T1 (de)
AU (1) AU2003270190B2 (de)
BR (2) BR0314258A (de)
CA (1) CA2498249C (de)
DE (1) DE60320425T2 (de)
ES (1) ES2304526T3 (de)
NZ (1) NZ542733A (de)
WO (1) WO2004024769A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040052817A1 (en) * 2002-09-13 2004-03-18 Peter Geldhof Ostertagia vaccine
BR0314273A (pt) * 2002-09-13 2005-07-19 Ovita Ltd Inibidor de protease de aspartil como um alérgeno de nematódeo
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB894603A (en) * 1959-09-02 1962-04-26 Allen & Hanburys Ltd Improvements in or relating to vaccines
AU7734994A (en) 1993-09-28 1995-04-18 Meat Research Corporation Protective antigens against parasites
US5753787A (en) * 1995-04-10 1998-05-19 Yale University Nucleic acids encoding ancylostoma secreted protein
US5759782A (en) * 1995-06-07 1998-06-02 The United States Of America Cellular apoptosis susceptibility protein (CSP) and antisense CSP
US6017757A (en) * 1997-02-20 2000-01-25 Mississippi State University Isolated viable nematode intestinal cells
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
US20040052817A1 (en) * 2002-09-13 2004-03-18 Peter Geldhof Ostertagia vaccine

Also Published As

Publication number Publication date
US20100209446A1 (en) 2010-08-19
US20050271683A1 (en) 2005-12-08
AU2003270190B2 (en) 2008-09-04
EP1539820B1 (de) 2008-04-16
DE60320425T2 (de) 2008-07-31
CA2498249C (en) 2016-09-06
NZ542733A (en) 2007-06-29
US20090028892A1 (en) 2009-01-29
US7718179B2 (en) 2010-05-18
WO2004024769A2 (en) 2004-03-25
ES2304526T3 (es) 2008-10-16
CA2498249A1 (en) 2004-03-25
EP1539820A2 (de) 2005-06-15
US7264812B2 (en) 2007-09-04
BRPI0314258B1 (pt) 2019-07-09
BR0314258A (pt) 2005-07-26
AR041243A1 (es) 2005-05-11
WO2004024769A3 (en) 2004-06-03
ATE392435T1 (de) 2008-05-15
US20040052817A1 (en) 2004-03-18
US8227584B2 (en) 2012-07-24
AU2003270190A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
IS7831A (is) Bóluefni
NO20050132D0 (no) Vaksinesammensetning
IS7547A (is) Ónæmisvaldandi samsetningar
NO20054608D0 (no) Influensavirusvaksine
IS7716A (is) Hringlaga heterósambönd
ATE457980T1 (de) Aryloxime
ATE534648T1 (de) C-6-modifizierte indazolylpyrrolotriazine
IS8387A (is) Ónæmisvaldandi samsetningar
ATE318817T1 (de) Aza-arylpiperazine
ATE427876T1 (de) Luftkissenboot
DK1427444T3 (da) West-nil-vaccine
NO20033882L (no) Vaksine
ATE349458T1 (de) Etonogestrelester
DE60327447D1 (de) Pflaster
IS8325A (is) Bóluefni
DE60328408D1 (de) Impfstoff
ATA1572002A (de) Managementspleisskassette
NO20051561D0 (no) Vaksine
ATA4142004A (de) Trägerverbau
ATE469773T1 (de) Zugöse
ATA19152002A (de) Hubkupplung
DE60320425D1 (de) Ostertagia-impfstoff
ATE396192T1 (de) N-sulfonylaminothiazole
FR2839258B1 (fr) Deambulateur-siege
DE10244834B8 (de) Suszeptometer

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: GELDHOF, PETER, B-9820 MERELBEKE, BE

Inventor name: VERCAUTEREN, ISABEL, B-9550 WOUBRECHTEGEM, BE

Inventor name: CLAEREBOUT, EDWIN, B-9160 LOKEREN, BE

Inventor name: VERCRUYSSE, JOZEF, B-9000 GENT, BE

Inventor name: DE MAERE, VEERLE, B-9000 GENT, BE

8364 No opposition during term of opposition